ARTICLE | Company News
ElexoPharm, Merck deal
May 24, 2010 7:00 AM UTC
ElexoPharm and Merck partnered to develop candidates targeting aldosterone synthase ( ALDOS; CYP11B2) to treat cardiovascular disease. Merck is responsible for all development, regulatory filings, m...